IP Library Granted Patent US 11,607,568
Granted Patent B2
US 11,607,568 · App. 17/350,848 · Granted Mar 21, 2023

Method and apparatus for pulmonary interventions

Inventors: Reinhard J. Warnking (Westlake, FL); Satoshi Nishiaoki (Centereach, NY)
Assignee: AERWAVE MEDICAL, INC.
A61N7/00A61B8/085A61B8/12A61B1/00082A61N2007/0004A61N2007/0043A61N2007/0052
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,607,568
App. No.
17/350,848
Granted
Mar 21, 2023
Kind
B2
Abstract

Apparatus and methods for deactivating bronchial nerves extending along the secondary bronchial branches of a mammalian subject to treat asthma and related conditions. An ultrasonic transducer ( 11 ) is inserted into the bronchus as, for example, by advancing the distal end of a catheter ( 10 ) bearing the transducer into the secondary bronchial section to be treated. The ultrasonic transducer emits circumferential ultrasound so as to heat tissues throughout circular impact volume ( 13 ) as, for example, at least about 1 cm 3 encompassing the bronchus to a temperature sufficient to inactivate nerve conduction but insufficient to cause rapid ablation or necrosis of the tissues. The treatment can be performed without locating or focusing on individual bronchial nerves. The apparatus and methods utilized for lung tumor ablation.

Claims (29)

1. A method for performing pulmonary interventions in a mammalian subject, comprising:

providing an ultrasound catheter having an ultrasound transducer at a distal end;

inserting the ultrasound catheter into a bronchus of a bronchial system of the mammalian subject so that the ultrasound transducer is disposed proximate to a treatment site;

while the ultrasound transducer is disposed proximate to the treatment site, operating an actuator or control unit electrically connected to the ultrasound transducer, to energize the ultrasound transducer to emit a short pulse at a sub-therapeutic level;

receiving via the ultrasound transducer an ultrasound echo from organic tissues of the mammalian subject in response to the short pulse, the ultrasound echo being a volume-integrated A-mode signal;

operating the actuator or control unit to process the volume integrated A-mode signal, which represents an accumulated intensity of the circumferential ultrasound echoes;

analyzing the volume integrated A-mode signal to determine longitudinal locations of cartilage along the bronchus; and

activating the ultrasound transducer to transmit ultrasound therapeutic waveform energy through the bronchus at longitudinal locations without cartilage,

wherein the ultrasound transducer is disposed inside a balloon attached to the distal end of the ultrasound catheter, further comprising analyzing the volume integrated A-mode signal to detect presence of air pockets or trapped air between the balloon and surrounding tissue, the activating of the ultrasound transducer to transmit ultrasound therapeutic waveform energy being carried out only when analyzing of the volume integrated A-mode signal reveals an absence of air, thereby ensuring complete circumferential coupling.

2. A method for performing pulmonary interventions in a mammalian subject, comprising:

inserting an ultrasound transducer into a bronchus of the mammalian subject so that the ultrasound transducer is disposed proximate to a treatment site;

while the ultrasound transducer is disposed proximate to the treatment site, operating an actuator or control unit electrically connected to the ultrasound transducer, to energize the ultrasound transducer to emit a pulse at a sub-therapeutic level;

receiving, via the ultrasound transducer, ultrasound echoes from organic tissues of the mammalian subject in response to the pulse;

operating the ultrasound transducer to produce a volume-integrated A-mode signal representing an accumulated intensity of the ultrasound echoes;

operating the actuator or control unit to process and analyze the volume integrated A-mode signal to determine presence of cartilage along the bronchus;

activating the ultrasound transducer to transmit ultrasound therapeutic waveform energy through a wall of the bronchus at one or more locations along the bronchus determined by the analyzing of the volume integrated A-mode signal to be without cartilage; and

wherein the ultrasound transducer is disposed inside a balloon, further comprising operating the actuator or control unit to analyze the volume integrated A-mode signal to detect presence of air pockets or trapped air between the balloon and surrounding tissue, the activating of the ultrasound transducer to transmit ultrasound therapeutic waveform energy being carried out only when analyzing of the volume integrated A-mode signal reveals an absence of air, thereby ensuring complete circumferential coupling.

3. The method of claim 2 , wherein the activating of the ultrasound transducer includes longitudinally shifting the ultrasound transducer along the bronchus to position the ultrasound transducer at the one or more locations along the bronchus without cartilage.

4. The method of claim 2 wherein the ultrasound transducer includes a longitudinal array of separately activatable cylindrical transducer elements and the activating of the ultrasound transducer includes energizing a selected one of the separately activatable transducer elements to transmit the ultrasound therapeutic waveform energy through the wall of the bronchus at the one or more locations along the bronchus without cartilage.

5. The method of claim 2 , further comprising operating the actuator or control unit to measure a time delay of the volume integrated A-mode signal and therewith determine size of a bronchial section, also comprising operating the actuator or control unit to control the ultrasound transducer to vary the amount of the therapeutically effective ultrasound energy in accordance with the determined size of the bronchial section taking into account catheter efficiency variations.

6. A method for performing pulmonary interventions in a mammalian subject, comprising:

providing an ultrasound transducer and a balloon;

inserting the ultrasound transducer and the balloon into a bronchus of the mammalian subject so that the ultrasound transducer and balloon are disposed proximate to a treatment site, with the ultrasound transducer inside the balloon;

while the ultrasound transducer and the balloon are disposed proximate to the treatment site, inflating the balloon with a liquid so that an outer surface of the balloon is in contact with the bronchus;

thereafter operating an actuator or control unit electrically connected to the ultrasound transducer, to energize the ultrasound transducer to emit a pulse at a sub-therapeutic level;

receiving, via the ultrasound transducer, ultrasound echoes from organic tissues of the mammalian subject in response to the pulse;

operating the ultrasound transducer to produce a volume-integrated A-mode signal representing an accumulated intensity of the ultrasound echoes;

analyzing the volume integrated A-mode signal to detect presence of air pockets or trapped air between the balloon and surrounding tissue; and

activating the ultrasound transducer to transmit ultrasound therapeutic waveform energy into the surrounding tissue and to the treatment site only when analyzing of the volume integrated A-mode signal reveals an absence of air between the balloon and the bronchus, thereby ensuring complete circumferential coupling.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Jun 30, 2021
From: WARNKING, REINHARD J; NISHIAOKI, SATOSHI
To: AERWAVE MEDICAL, INC.
Reel/Frame 056722/0472 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2021
From: WARNKING, REINHARD J; NISHIAOKI, SATOSHI
To: AERWAVE MEDICAL, INC.
Reel/Frame 056578/0820 →
Continuity (3)
Continuation In Part PCTUS2021015825 · Jan 29, 2021
Provisional Application 63002555 · Mar 31, 2020
Related Publication 20210316161A1 · Oct 14, 2021
Cited By (3)
US 12,502,559 US 12,582,847 US 12,594,438